The long-standing debate over patenting genes is back in the limelight. The American Civil Liberties Union (ACLU) has filed a case charging that patents on BRCA1 and BRCA2, genes associated with breast and ovarian cancer, are unconstitutional and invalid. Myriad Genetics currently holds the patents to these genes and provides a diagnostic test that reportedly costs over $3,000.

here’s a link

There’s a new soulflower remix; and it’s kinda fun.

listen here